title: Relevance of AIDS treatment with two nucleoside analogues alone.
authors.affiliation: Division of HIV/AIDS Prevention-Surveillance and Epidemiology, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
authors.forename: P J
authors.initials: PJ
authors.lastname: Weidle
authors.forename: E
authors.initials: E
authors.lastname: Mbidde
authors.forename: G
authors.initials: G
authors.lastname: Djomand
authors.forename: E M
authors.initials: EM
authors.lastname: Lackritz
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000401:mortality; D019380:Anti-HIV Agents / Q000008:administration & dosage*; D016049:Didanosine / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D006801:Humans; D015996:Survival Rate; D016047:Zalcitabine / Q000008:administration & dosage*; D015215:Zidovudine / Q000008:administration & dosage*
chemical_list: D019380:Anti-HIV Agents; D015215:Zidovudine; D016047:Zalcitabine; D016049:Didanosine